All lobbying filings

AMERICAN TOWER CORPORATION

AMERICAN TOWER CORPORATION filed a Q1 report for AMERICAN TOWER CORPORATION on April 21, 2025.

Lobbying for AMERICAN TOWER CORPORATION

All filings by AMERICAN TOWER CORPORATION · Everything AMERICAN TOWER CORPORATION has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$2,150,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Financial Institutions/Investments/Securities

Issues relating to corporate disclosure - no specific legislation

Taxation/Internal Revenue Code

Issues related to international and domestic tax provisions as applied to real estate investment trusts

Telecommunications

Issues pertaining to telecommunications towers and real estate - no specific legislation Issues related to global telecommunications policy- no specific legislation

Communications/Broadcasting/Radio/TV

Telecommunications infrastructure issues - no specific legislation Issues related to NTIA, including broadband funding programs Issues related to 5G and wireless communications deployment referencing the American Broadband Deployment Act, HR 3557, from the 118th Congress Issues related to the definition of eligible project costs -- no specific legislation

Trade (domestic/foreign)

Issues pertaining to global trade - no specific legislation

Bills named in this filing 1

H.R. 3557
American Broadband Deployment Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.